Prevalence of Radix Entomolaris and Middle Mesial Canal in an Egyptian Sub-population Using Cbct. (RE MMC CBCT)

January 26, 2026 updated by: Ali Ayman Ali, Cairo University

Prevalence of Radix Entomolaris and Middle Mesial Canal in Lower Permanent Molars in an Egyptian Sub-Population Using CBCT: Cross Sectional Study

The aim of the study is to determine the prevalence of RE and MMCs in mandibular first and second molars among an Egyptian sub- population.

Study Overview

Status

Not yet recruiting

Detailed Description

Primary Objective is to determine the prevalence of RE and MMC in mandibular molars within an Egyptian sub_population using CBCT analysis.

Study Type

Observational

Enrollment (Estimated)

395

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Egyptian sub-population

Description

Inclusion Criteria:

  • Participants aged 18 years and above.
  • Egyptian individuals with permanent mandibular molars had CBCT imaging.
  • High-quality CBCT scans with clear visualization of mandibular molars.

Exclusion Criteria:

  • Non- Egyptian patients.
  • Molars are badly broken down with root defect such as root caries, or root resorption.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Lower Permanent Molars in an Egyptian Sub- Population
Egyptian Sub- Population

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of Radix Entomolaris in Lower Permanent Molars
Time Frame: 1 year
frequency and percentage of the prevalence of Radix Entomolaris
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of Middle Mesial Canal in Lower Permanent Molars in an Egyptian Sub- Population Using CBCT: Cross Sectional Study.
Time Frame: 1 year
Using CBCT to determine the prevalence of and Middle Mesial Canal frequency and prevalence in Lower Permanent Molars.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Talabani RM, Abdalrahman KO, Abdul RJ, Babarasul DO, Hilmi Kazzaz S. Evaluation of Radix Entomolaris and Middle Mesial Canal in Mandibular Permanent First Molars in an Iraqi Subpopulation Using Cone-Beam Computed Tomography. Biomed Res Int. 2022 Jul 11;2022:7825948. doi: 10.1155/2022/7825948. PMID: 35860794; PMCID: PMC9293536.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

January 26, 2026

First Submitted That Met QC Criteria

January 26, 2026

First Posted (Actual)

February 3, 2026

Study Record Updates

Last Update Posted (Actual)

February 3, 2026

Last Update Submitted That Met QC Criteria

January 26, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe